Analyze Diet
Frontiers in pain research (Lausanne, Switzerland)2024; 5; 1373759; doi: 10.3389/fpain.2024.1373759

The pharmacokinetics and pharmacodynamics of fentanyl administered via transdermal patch in horses.

Abstract: Understanding the pharmacokinetics and pharmacodynamics of fentanyl in horses is crucial for optimizing pain management strategies in veterinary medicine. Unassigned: Six adult horses were enrolled in a randomized crossover design. Treatments included: placebo, two 100 mcg/h patches (LDF), four 100 mcg/h patches (MDF), and six 100 mcg/h patches (HDF). Patches were in place for 72 h. Blood was obtained for fentanyl plasma concentration determination, thermal threshold, mechanical threshold, heart rate, respiratory rate, and rectal temperature were obtained prior patch placement and at multiple time points following patch placement for the following 96 h. Fentanyl plasma concentration was determined using LC-MS/MS. Data were analyzed using a generalized mixed effects model. Unassigned: Mean (range) maximum plasma concentration (Cmax), time to Cmax, and area under the curve extrapolated to infinity were 1.39 (0.82-1.82), 2.64 (1.21-4.42), 4.11 (2.78-7.12) ng/ml, 12.7 (8.0-16.0), 12.7 (8.0-16.0), 12 (8.0-16.0) h, 42.37 (27.59-55.56), 77.24 (45.62-115.06), 120.34 (100.66-150.55) h ng/ml for LDF, MDF, and HDF, respectively. There was no significant effect of treatment or time on thermal threshold, mechanical threshold, respiratory rate, or temperature ( > 0.063). There was no significant effect of treatment on heart rate ( = 0.364). There was a significant effect of time ( = 0.003) on heart rate with overall heart rates being less than baseline at 64 h. Unassigned: Fentanyl administered via transdermal patch is well absorbed and well tolerated but does not result in an anti-nociceptive effect as measured by thermal and mechanical threshold at the doses studied.
Publication Date: 2024-03-20 PubMed ID: 38571562PubMed Central: PMC10987731DOI: 10.3389/fpain.2024.1373759Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research focuses on understanding how fentanyl, delivered through a transdermal patch system, is absorbed, distributed, metabolized, and expelled in horses. It aims to determine the potential usefulness of this method for pain management in horses.

Study Design

  • The research was conducted on six adult horses using a randomized crossover design.
  • Treatments were divided into four groups: placebo, low-dose fentanyl (two 100mcg/h patches), medium-dose fentanyl (four 100mcg/h patches), and high-dose fentanyl (six 100mcg/h patches).
  • The patches were kept on for 72 hours, following which numerous measurements such as fentanyl plasma concentrations, thermal threshold, mechanical threshold, heart rate, respiratory rate, and rectal temperature were obtained before and after patch placement.
  • Fentanyl plasma concentration was determined using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
  • The data were analyzed using a generalized mixed effects model.

Results

  • The researchers found variations in the plasma concentration levels of fentanyl depending on the dosage.
  • They did not identify any significant effect of the treatment or time on the thermal threshold, mechanical threshold, respiratory rate, or temperature, suggesting no observed onset of side effects related to these parameters.
  • Similarly, there was no significant influence of the treatment on heart rate.
  • However, the researchers noticed a significant decrease in heart rate over time, particularly 64 hours after the patches were applied, although the connection to the fentanyl treatment is not explicitly stated.

Conclusion

  • Overall, the study concluded that fentanyl delivered through a transdermal patch was well absorbed in horses, and they generally tolerated it well.
  • Despite this, researchers found no significant anti-nociceptive (pain-blocking) effect evidenced by the thermal and mechanical thresholds at the administered dosages.

Implications

  • This research highlights the need for evaluating the precise dosage of fentanyl that would yield sufficient pain-relief effects when administered via transdermal patches.
  • Moreover, the impact of prolonged fentanyl usage on a horse’s heart rate warrants further investigation to ensure the safe use of this pain management technique in veterinary medicine.

Cite This Article

APA
Reed RA, Berghaus LJ, Reynolds RM, Holmes BT, Krikorian AM, Sakai DM, Ishikawa Y, Knych HK. (2024). The pharmacokinetics and pharmacodynamics of fentanyl administered via transdermal patch in horses. Front Pain Res (Lausanne), 5, 1373759. https://doi.org/10.3389/fpain.2024.1373759

Publication

ISSN: 2673-561X
NlmUniqueID: 9918227269806676
Country: Switzerland
Language: English
Volume: 5
Pages: 1373759
PII: 1373759

Researcher Affiliations

Reed, Rachel A
  • Department of Large Animal Medicine, University of Georgia, Athens, GA, United States.
Berghaus, Londa J
  • Department of Large Animal Medicine, University of Georgia, Athens, GA, United States.
Reynolds, Rose M
  • Department of Large Animal Medicine, University of Georgia, Athens, GA, United States.
Holmes, Brittany T
  • Department of Large Animal Medicine, University of Georgia, Athens, GA, United States.
Krikorian, Anna M
  • Department of Large Animal Medicine, University of Georgia, Athens, GA, United States.
Sakai, Daniel M
  • Department of Small Animal Medicine and Surgery, University of Georgia, Athens, GA, United States.
Ishikawa, Yushun
  • Sydney School of Veterinary Science, University of Sydney, Camperdown, NSW, Australia.
Knych, Heather K
  • K.L. Maddy Equine Analytical Pharmacology Laboratory, School of Veterinary Medicine, University of California Davis, Davis, CA, United States.
  • Department of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, CA, United States.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

References

This article includes 19 references
  1. Bennett RC, Steffey EP. Use of opioids for pain and anesthetic management in horses.. Vet Clin North Am Equine Pract (2002) 18(1):47–60.
    doi: 10.1016/S0749-0739(02)00011-1pubmed: 12064182google scholar: lookup
  2. Clutton RE. Opioid analgesia in horses.. Vet Clin North Am Equine Pract (2010) 26(3):493–514.
    doi: 10.1016/j.cveq.2010.07.002pubmed: 21056296google scholar: lookup
  3. Love EJ, Pelligand L, Taylor PM, Murrell JC, Sear JW. Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses.. Vet Anaesth Analg (2015) 42(1):17–29.
    doi: 10.1111/vaa.12165pubmed: 24735059google scholar: lookup
  4. Eberspacher E, Stanley SD, Rezende M, Steffey EP. Pharmacokinetics and tolerance of transdermal fentanyl administration in foals.. Vet Anaesth Analg (2008) 35(3):249–55.
  5. Echelmeyer J, Taylor PM, Hopster K, Rohn K, Delarocque J, Kastner SBR. Effect of fentanyl on thermal and mechanical nociceptive thresholds in horses and estimation of anti-nociceptive plasma concentration.. Vet J (2019) 249:82–8.
    doi: 10.1016/j.tvjl.2019.05.012pubmed: 31239171google scholar: lookup
  6. Kamerling SG, DeQuick DJ, Weckman TJ, Tobin T. Dose-related effects of fentanyl on autonomic and behavioral responses in performance horses.. Gen Pharmacol (1985) 16(3):253–8.
    doi: 10.1016/0306-3623(85)90078-3pubmed: 4018540google scholar: lookup
  7. Knych HK, Steffey EP, Casbeer HC, Mitchell MM. Disposition, behavioural and physiological effects of escalating doses of intravenously administered fentanyl to young foals.. Equine Vet J (2015) 47(5):592–8.
    doi: 10.1111/evj.12318pubmed: 24978306google scholar: lookup
  8. Maxwell LK, Thomasy SM, Slovis N, Kollias-Baker C. Pharmacokinetics of fentanyl following intravenous and transdermal administration in horses.. Equine Vet J (2003) 35(5):484–90.
    doi: 10.2746/042516403775600415pubmed: 12875327google scholar: lookup
  9. Sanchez LC, Robertson SA, Maxwell LK, Zientek K, Cole C. Effect of fentanyl on visceral and somatic nociception in conscious horses.. J Vet Intern Med (2007) 21(5):1067–75.
  10. Thomasy SM, Mama KR, Whitley K, Steffey EP, Stanley SD. Influence of general anaesthesia on the pharmacokinetics of intravenous fentanyl and its primary metabolite in horses.. Equine Vet J (2007) 39(1):54–8.
    doi: 10.2746/042516407X153011pubmed: 17228596google scholar: lookup
  11. Thomasy SM, Slovis N, Maxwell LK, Kollias-Baker C. Transdermal fentanyl combined with nonsteroidal anti-inflammatory drugs for analgesia in horses.. J Vet Intern Med (2004) 18(4):550–4.
  12. Muijsers RB, Wagstaff AJ. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.. Drugs (2001) 61(15):2289–307.
  13. Mystakidou K, Katsouda E, Tsilika E, Parpa E, Vlahos L. Transdermal therapeutic fentanyl-system (TTS-F).. In Vivo (2004) 18(5):633–42.
    doi: 10.1016/0304-3959(89)90130-9pubmed: 15523905google scholar: lookup
  14. Gourlay GK, Kowalski SR, Plummer JL, Cherry DA, Gaukroger P, Cousins MJ. The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects.. Pain (1989) 37(2):193–202.
    doi: 10.1016/0304-3959(89)90130-9pubmed: 2748192google scholar: lookup
  15. Robinson TM, Kruse-Elliott KT, Markel MD, Pluhar GE, Massa K, Bjorling DE. A comparison of transdermal fentanyl versus epidural morphine for analgesia in dogs undergoing major orthopedic surgery.. J Am Anim Hosp Assoc (1999) 35(2):95–100.
    doi: 10.5326/15473317-35-2-95pubmed: 10102175google scholar: lookup
  16. Skrzypczak H, Reed R, Barletta M, Quandt J, Sakai D. A retrospective evaluation of the effect of perianesthetic hydromorphone administration on the incidence of postanesthetic signs of colic in horses.. Vet Anaesth Analg (2020) 47(6):757–62.
    doi: 10.1016/j.vaa.2020.06.003pubmed: 32830037google scholar: lookup
  17. Boscan P, Van Hoogmoed LM, Farver TB, Snyder JR. Evaluation of the effects of the opioid agonist morphine on gastrointestinal tract function in horses.. Am J Vet Res (2006) 67(6):992–7.
    doi: 10.2460/ajvr.67.6.992pubmed: 16740092google scholar: lookup
  18. Lehmann KA, Zech D. Transdermal fentanyl: clinical pharmacology.. J Pain Symptom Manage (1992) 7(3 Suppl):S8–16.
    doi: 10.1016/0885-3924(92)90048-Mpubmed: 1517637google scholar: lookup
  19. Menozzi A, Pozzoli C, Zullian C, Poli E, Serventi P, Bertini S. Inhibition of motility in isolated horse small intestine is mediated by κ but not µ opioid receptors.. Equine Vet J (2012) 44(3):368–70.

Citations

This article has been cited 0 times.